Archives
-
Concanavalin A Targets Conserved Coronavirus N-Glycans
2026-08-08
A 2026 Journal of Virology study identifies conserved high-mannose N-glycans near the coronavirus spike S2′ cleavage site as a broad-spectrum antiviral vulnerability. Using fusion, pseudovirus, authentic-virus, biochemical, and mouse infection models, the authors show that concanavalin A blocks spike activation and viral entry rather than targeting rapidly changing antibody epitopes.
-
AP20187: Transforming Conditional Gene Therapy with Precisio
2026-08-07
Explore how AP20187 as a chemical inducer of dimerization bridges mechanistic rigor with translational promise, empowering researchers to control gene expression and cellular behavior for next-generation therapies. This article integrates foundational science, competitive analysis, and strategy for deploying APExBIO’s AP20187 in regulated cell therapy and disease modeling, with direct evidence from recent tumor microenvironment research.
-
PYR-41: Selective Inhibitor of Ubiquitin-Activating Enzyme E
2026-08-06
PYR-41 is a small molecule inhibitor of Ubiquitin-Activating Enzyme E1, effectively blocking ubiquitin-proteasome system function in vitro and in vivo. It provides a robust tool for dissecting protein degradation and NF-κB signaling, with clear benchmarks in inflammation and sepsis models. This dossier details its mechanisms, use parameters, and boundaries for research applications.
-
Solving Lab Assay Challenges with FLAG tag Peptide (DYKDDDDK
2026-08-04
This article provides scenario-driven, evidence-based guidance on optimizing recombinant protein workflows using FLAG tag Peptide (DYKDDDDK) (SKU A6002). By addressing real laboratory pain points, it highlights how SKU A6002 from APExBIO ensures assay reproducibility, high purity, and compatibility—backed by quantitative data and peer-reviewed references.
-
Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X
2026-08-03
This reagent prevents protein degradation and loss of phosphorylation during extraction from diverse biological samples, without introducing metal chelators like EDTA. It is best used where preservation of both protein structure and post-translational modifications is essential, but is not suitable for protocols requiring metal chelation.
-
Batimastat (BB-94) in MMP Inhibition: Protocols and NMJ Insi
2026-08-02
Batimastat (BB-94) provides precise, nanomolar-level MMP inhibition, empowering researchers to dissect proteolytic mechanisms in cancer and synaptic development. This guide translates new insights from neuromuscular junction studies into actionable protocols and troubleshooting strategies for both in vitro and in vivo assays.
-
Ganetespib (STA-9090): Mechanistic Insights and Protocol Inn
2026-07-30
Explore the advanced mechanism and research applications of Ganetespib (STA-9090), a potent Hsp90 inhibitor, with practical assay guidance and new scientific insights. This article offers unique protocol strategies and contextualizes breakthroughs in regulated cell death for cancer research.
-
c-Myc tag Peptide: Molecular Precision in Transcriptional Re
2026-07-30
Explore how the c-Myc tag Peptide advances immunoassays and transcription factor research. This in-depth article uniquely addresses the mechanistic nuances and assay optimization strategies that set c-Myc Peptide-based workflows apart.
-
DAMGO and Central Circuits: Redefining Opioid Pain Research
2026-07-29
Recent advances in opioid receptor signaling research, particularly using DAMGO, are reshaping our understanding of analgesic mechanisms and side effects. This article integrates mechanistic insights from central opioid pathways with strategic guidance for translational researchers, highlighting how selective µ-opioid receptor agonists like DAMGO enable unprecedented dissection of pain circuits, inform model selection, and help bridge preclinical findings to future therapeutic strategies.
-
NET-DNA Impairs ILC3-Driven Intestinal Repair via CCDC25
2026-07-28
This study reveals that DNA from neutrophil extracellular traps (NETs) impairs the intestinal epithelial repair function of group 3 innate lymphoid cells (ILC3s) by engaging the receptor CCDC25, leading to reduced IL-22 secretion. These findings clarify a molecular mechanism of mucosal barrier dysfunction in ulcerative colitis and present potential targets for therapeutic intervention.
-
S Tag Peptide: Practical Guide for Fusion Tag Workflows
2026-07-26
S Tag Peptide (SKU A6007) addresses persistent issues of poor recombinant protein solubility and unreliable detection in molecular biology workflows. Researchers should use it for fusion tag applications requiring high solubility and antibody-based purification, but avoid scenarios demanding ethanol solubility or long-term solution storage.
-
METTL3-m6A-LEPR Axis Regulates Fetal Growth Restriction in P
2026-07-25
This study demonstrates that reduced METTL3-mediated m6A modification of the leptin receptor (LEPR) in placenta contributes to fetal growth restriction (FGR) by impairing trophoblast cell proliferation and invasion. The findings clarify a mechanistic pathway for FGR and highlight potential biomarkers for predicting adverse pregnancy outcomes.
-
Single-Molecule Screening Identifies Fast-Dissociating V5 An
2026-07-24
Miyoshi et al. introduce a semi-automated single-molecule microscopy screen to rapidly identify fast-dissociating, highly specific monoclonal antibodies directly from hybridoma cultures. This work advances the development of antibody probes for multiplexed super-resolution imaging and enhances workflows using V5 epitope tagging.
-
S Tag Peptide (A6007): Practical Guide for Protein Fusion Ta
2026-07-24
The S Tag Peptide (A6007) addresses challenges in recombinant protein solubility, detection, and purification by serving as a highly soluble, antibody-detectable fusion tag. It is best suited for workflows requiring affinity-based detection or purification in aqueous systems but is not appropriate for applications needing ethanol solubility or enzymatic activity from the peptide alone.
-
PRC2 Recruitment Mechanisms: DNA, RNA, and Chromatin Context
2026-07-23
This study dissects how Polycomb Repressive Complex 2 (PRC2) is recruited to chromatin, revealing that linker DNA, rather than histone modifications or complex variants, is the dominant determinant of PRC2 binding. The findings redefine models of PRC2 regulation and provide mechanistic clarity on the interplay between DNA, RNA, and chromatin modifications in epigenetic gene silencing.